Profil bibliographique

Alice Boilève

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

179Publications signalées

2231Citations signalées

6Affiliations récentes

Institutions déclarées

Inserm Université Paris-Saclay Institut Gustave Roussy Laboratoire d'études sur les monothéismes Fondation ARC pour la Recherche sur le Cancer Bicêtre Hospital

Domaines associés

Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsCholangiocarcinoma and Gallbladder Cancer StudiesColorectal Cancer Treatments and StudiesHepatocellular Carcinoma Treatment and Prognosis

Publications récentes

Accès ouvert 2026 erratumOpenAlex

Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians

Elie Rassy, Suzette Delaloge, Yannis Slaouti, T. Pudlarz et autres

0 citationsBritish Journal of Cancer

Accès ouvert 2026 articleOpenAlex

Third-line treatment of biliary tract cancers in a real-life setting

Alice Boilève, A. Mihaele, M. Khoury, A. Hollebecque et autres

0 citationsESMO Gastrointestinal Oncology

2026 articleOpenAlex

Outcomes of patients treated by FGFR inhibitors according to alteration types: An agnostic monocentric retrospective cohort

Cédric Pobel, Hassan Badreddine, Cristina Smolenschi, Alice Boilève et autres

0 citationsEuropean Journal of Cancer

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure 6 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S1 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S2 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S5 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S4 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S1 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S3 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S3 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S2 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.